Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
1998-6-4
|
| pubmed:abstractText |
To study the long-term efficacy and safety of the drug finasteride (Proscar) for benign prostatic hyperplasia and to evaluate whether an improved effect beyond 1 year was due to continuous selection of 'responders'. We also wanted to investigate whether drop-outs differed in short-term responses to those completing the trial.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0302-2838
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
33
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
312-7
|
| pubmed:dateRevised |
2010-11-18
|
| pubmed:meshHeading |
pubmed-meshheading:9555559-5-alpha Reductase Inhibitors,
pubmed-meshheading:9555559-Double-Blind Method,
pubmed-meshheading:9555559-Enzyme Inhibitors,
pubmed-meshheading:9555559-Finasteride,
pubmed-meshheading:9555559-Humans,
pubmed-meshheading:9555559-Male,
pubmed-meshheading:9555559-Prostate,
pubmed-meshheading:9555559-Prostatic Hyperplasia,
pubmed-meshheading:9555559-Urodynamics
|
| pubmed:year |
1998
|
| pubmed:articleTitle |
Maximum efficacy of finasteride is obtained within 6 months and maintained over 6 years. Follow-up of the Scandinavian Open-Extension Study. The Scandinavian Finasteride Study Group.
|
| pubmed:affiliation |
Department of Urology, Karolinska Hospital, Stockholm, Sweden.
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study
|